(Q41871660)

13 October 2017

Acquired hemophilia as the cause of life-threatening hemorrhage in a 94-year-old man: a case report (English)

1 reference

13 October 2017

0 references

0 references

1 reference

1

1 reference

13 October 2017

Jonelle Raphael

2

1 reference

13 October 2017

Elizabeth Blanchard

series ordinal

3

1 reference

13 October 2017

Rekha Parameswaran

series ordinal

4

1 reference

13 October 2017

language of work or name

English

0 references

publication date

29 July 2010

1 reference

Journal of Medical Case Reports

13 October 2017

1 reference

13 October 2017

4

1 reference

13 October 2017

231

1 reference

Creative Commons Attribution 2.0 Generic

13 October 2017

start time

29 July 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

International recommendations on the diagnosis and treatment of patients with acquired hemophilia A

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918632

Acquired factor VIII inhibitors

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918632

A systematic overview of the first pasteurised VWF/FVIII medicinal product, Haemate P/ Humate -P: history and clinical performance

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918632

A benefit-risk review of systemic haemostatic agents: part 1: in major surgery

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918632

Treatment of factor XI inhibitor using recombinant activated factor VIIa

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918632

Case Report: Successful Use of Antifibrinolytic Therapy in Acquired Factor VIII Deficiency

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918632

Haemate P von Willebrand factor/factor VIII concentrate: 25 years of clinical experience

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918632

Life-threatening bleeding from refractory acquired FVIII inhibitor successfully treated with rituximab

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918632

Hemostasis in acquired hemophilia--role of intracavitary instillation of EACA.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918632

Does Sjögren's syndrome predispose surgical patients to acquired hemophilia?

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2918632

18 August 2018

Identifiers

DOI

10.1186/1752-1947-4-231

1 reference

Dimensions Publication ID

13 October 2017

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1752-1947-4-231

1 reference

13 October 2017

PubMed publication ID

20670435

1 reference